Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Frontiers in Pediatrics|April 17, 2023
Population pharmacokinetics of vancomycin in very low birth weight neonatesAbdullah Alsultan, Manea Fares Al Munjem, Khulood Mohammed Atiq, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 27, 2024
Novel β-lactam-β-lactamase inhibitors as monotherapy versus combination for the treatment of drug-resistant Pseudomonas aeruginosa infections: A multicenter cohort studyThamer A Almangour, Leen Ghonem, Dareen Alassiri, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 19, 2020
Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi ArabiaAbdulrhman Mohana, Tarek Sulaiman, Nagla Mahmoud, et al.Antimicrobial Agents and Chemotherapy|July 5, 2023
Ceftolozane-Tazobactam Versus Ceftazidime-Avibactam for the Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa: a Multicenter Cohort StudyThamer A Almangour, Leen Ghonem, Dareen Alassiri, et al.Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Ceftazidime-Avibactam Versus Colistin for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Cohort StudyThamer A Almangour, Zakiyah Alkherb, Leen Ghonem, et al.Journal of Infection and Public Health|December 28, 2023
Whole genome sequencing of resistance and virulence genes in multi-drug resistant Pseudomonas aeruginosaReem S Almaghrabi, Guerrino Macori, Fionn Sheridan, et al.Journal of Global Antimicrobial Resistance|February 5, 2022
Ceftolozane-tazobactam vs. colistin for the treatment of infections due to multidrug-resistant Pseudomonas aeruginosa: a multicentre cohort studyThamer A Almangour, Ahmad Aljabri, Mohammed Al Musawa, et al.Expert Review of Anti-Infective Therapy|May 13, 2024
Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort studyThamer A Almangour, Hussain A Alali, Zakiyah Alkherb, et al.Journal of Global Antimicrobial Resistance|May 31, 2024
Trimethoprim-sulfamethoxazole versus levofloxacin for the treatment of Stenotrophomonas maltophilia infections: A multicentre cohort studyThamer A Almangour, Zakiyah Alkherb, Shatha Alruwaite, et al.Infection and Drug Resistance|March 20, 2026
Daptomycin Dosing Based on Adjusted Body Weight in Obese Patients versus Actual Body Weight: A Multicentre Cohort StudyThamer A Almangour, Latifa S Almosabhi, Rahaf Almojel, et al.Pageof 3